Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Chromium and Omega-3 are closely matched across evidence, studies, and safety.
Verdict
Likely helps
8 of 11 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
15 of 23 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Chromium and Omega-3 have evidence — compare verdict strength side-by-side.
200-1000mcg daily
With meals (especially carb-containing), Can split doses with meals
Chromium Picolinate
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
8-16 weeks
2-4 weeks
8-12 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis
Reproductive biology and endocrinology : RB&E (2025) · Meta analysis · n=5501
Inositol significantly decreased total cholesterol and triglyceride levels, while curcumin was most effective in improving low-density and high-density lipoprotein cholesterol levels.
Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials
Pharmacological research (2023) · Meta analysis · n=14223
Low to very low certainty evidence established chromium supplements as the most effective in reducing fasting blood glucose levels and homeostasis model assessment of insulin resistance (SUCRAs: 90.4% and 78.3%, respectively).
Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis
PeerJ (2023) · Meta analysis · n=2362
The network meta-analysis showed that carnitine, inositol, and probiotics reduced body weight and body mass index (BMI) compared to placebo, and carnitine outperformed the other supplements (SUCRAs: 96.04%, 97.73%, respectively).
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
Nature communications (2025) · Meta analysis · n=5205
Mean body mass index (BMI) was 27.5 kg/m2 (SD = 5.3), with 51% female and 17% Black race/ethnicity.
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Meta-analysis showed 17.24 mg/dL reduction in fasting glucose with stronger effects above 200 mcg/day. Effects primarily demonstrated in type 2 diabetes patients. Chromium picolinate shows higher bioavailability than other forms.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Both Chromium and Omega-3 are closely matched — the best choice depends on your specific health goals.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 75).
No known interactions between Chromium and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.